Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Lymphir

(LIM-fur)
A drug used to treat adults with stage I, stage II, or stage III cutaneous T-cell lymphoma that came back or did not get better after treatment with at least one other systemic therapy. It is also being studied in the treatment of other types of cancer. Lymphir is made by combining interleukin-2 (IL-2) with a bacterial toxin. The IL-2 part of the drug attaches to the cancer cells and the toxin kills them. Lymphir is a type of immunotoxin and a type of recombinant fusion protein. Also called denileukin diftitox.
More Information
Search NCI's Dictionary of Cancer Terms